NO940974L - Benzanilid-derivater som 5-HT1D antagonister - Google Patents
Benzanilid-derivater som 5-HT1D antagonisterInfo
- Publication number
- NO940974L NO940974L NO940974A NO940974A NO940974L NO 940974 L NO940974 L NO 940974L NO 940974 A NO940974 A NO 940974A NO 940974 A NO940974 A NO 940974A NO 940974 L NO940974 L NO 940974L
- Authority
- NO
- Norway
- Prior art keywords
- benzanilide derivatives
- ht1d antagonists
- ht1d
- antagonists
- benzanilide
- Prior art date
Links
- 102100027493 5-hydroxytryptamine receptor 1D Human genes 0.000 title 1
- 101710138068 5-hydroxytryptamine receptor 1D Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- ZVSKZLHKADLHSD-UHFFFAOYSA-N benzanilide Chemical class C=1C=CC=CC=1C(=O)NC1=CC=CC=C1 ZVSKZLHKADLHSD-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919119932A GB9119932D0 (en) | 1991-09-18 | 1991-09-18 | Chemical compounds |
| PCT/EP1992/002136 WO1993006084A1 (en) | 1991-09-18 | 1992-09-14 | Benzanilide derivatives as 5-ht1d antagonists |
| CN93100710A CN1089944A (zh) | 1991-09-18 | 1993-01-09 | N-苯甲酰苯胺衍生物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO940974L true NO940974L (no) | 1994-03-17 |
| NO940974D0 NO940974D0 (no) | 1994-03-17 |
Family
ID=36792802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940974A NO940974D0 (no) | 1991-09-18 | 1994-03-17 | Benzanilid-derivater som 5-HT1D antagonister |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5358948A (no) |
| EP (1) | EP0533267A1 (no) |
| JP (1) | JPH06107637A (no) |
| CN (2) | CN1073430A (no) |
| AU (2) | AU2568792A (no) |
| CA (1) | CA2078507A1 (no) |
| CZ (1) | CZ61194A3 (no) |
| FI (1) | FI941261A7 (no) |
| GB (1) | GB9119932D0 (no) |
| IL (1) | IL103199A0 (no) |
| MX (1) | MX9205278A (no) |
| NO (1) | NO940974D0 (no) |
| WO (1) | WO1993006084A1 (no) |
| ZA (1) | ZA927106B (no) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2276164A (en) * | 1993-03-17 | 1994-09-21 | Glaxo Group Ltd | Aniline and benzanilide derivatives |
| EP0712397B1 (en) * | 1993-08-06 | 1999-04-21 | Smithkline Beecham Plc | Amide derivatives as 5ht1d receptor antagonists |
| US5905080A (en) * | 1993-08-20 | 1999-05-18 | Smithkline Beecham, P.L.C. | Amide and urea derivatives as 5HT1D receptor antagonists |
| WO1995006637A1 (en) * | 1993-09-03 | 1995-03-09 | Smithkline Beecham Plc | Indole and indoline derivatives as 5ht1d receptor antagonists |
| EP0716656A1 (en) * | 1993-09-03 | 1996-06-19 | Smithkline Beecham Plc | Amide derivatives as 5ht1d receptor antagonists |
| WO1995011243A1 (en) * | 1993-10-19 | 1995-04-27 | Smithkline Beecham Plc | Benzanilide derivatives as 5ht-1d receptor antagonists |
| EP0733048A1 (en) * | 1993-12-07 | 1996-09-25 | Smithkline Beecham Plc | Heterocyclic biphenylylamides useful as 5ht1d antagonists |
| EP0758330A1 (en) * | 1994-05-06 | 1997-02-19 | Smithkline Beecham Plc | Biphenylcarboxamides useful as 5-ht1d antagonists |
| GB9410512D0 (en) * | 1994-05-25 | 1994-07-13 | Smithkline Beecham Plc | Novel treatment |
| JPH10500960A (ja) * | 1994-05-28 | 1998-01-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ１ｄ−アンタゴニスト活性を有するアミド誘導体 |
| FR2722788B1 (fr) * | 1994-07-20 | 1996-10-04 | Pf Medicament | Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant |
| GB9416972D0 (en) * | 1994-08-23 | 1994-10-12 | Smithkline Beecham Plc | Carbon side chain/indole/indolene |
| PL321048A1 (en) * | 1994-12-22 | 1997-11-24 | Smithkline Beecham Plc | Tetracyclic spiro- compounds, method of obtaining them and their application as antagonists of 5ht1d receptors |
| GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
| FR2740134B1 (fr) * | 1995-10-18 | 1998-01-09 | Pf Medicament | Derives d'amines cycliques d'aryl-piperazines, leur preparation et les compositions pharmaceutiques les contenant |
| ZA9756B (en) * | 1996-01-16 | 1997-07-17 | Warner Lambert Co | Process for preparing 4,6-disubstituted pyrido[3,4-d]-pyrimidines |
| FR2744449B1 (fr) * | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| FR2744450A1 (fr) * | 1996-02-02 | 1997-08-08 | Pf Medicament | Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| SE9601110D0 (sv) | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| GB9606396D0 (en) * | 1996-03-27 | 1996-06-05 | Smithkline Beecham Plc | Novel compounds |
| US6156783A (en) * | 1996-04-30 | 2000-12-05 | Smithkline Beecham P.L.C. | Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
| GB9625145D0 (en) * | 1996-12-03 | 1997-01-22 | Smithkline Beecham Plc | Novel compounds |
| DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| CA2274055A1 (en) * | 1996-12-19 | 1998-06-25 | Smithkline Beecham P.L.C. | N-piperazin-1-ylphenyl-benzamide derivatives |
| FR2761064B1 (fr) * | 1997-03-20 | 1999-06-04 | Pf Medicament | Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments |
| KR20010006487A (ko) * | 1997-04-18 | 2001-01-26 | 피터 기딩스 | 조합된 5ｈｔ1ａ, 5ｈｔ1ｂ 및 5ｈｔ1ｄ 수용체 길항 활성을 갖는 인돌 유도체 |
| SE9900190D0 (sv) | 1999-01-22 | 1999-01-22 | Astra Ab | New compounds |
| SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | Astra Ab | New compounds |
| WO1999007700A1 (en) * | 1997-08-09 | 1999-02-18 | Smithkline Beecham Plc | Bicyclic compounds as ligands for 5-ht1 receptors |
| SE9703376D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
| SE9703375D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
| GB9818914D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| GB9826412D0 (en) | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
| US6365591B1 (en) | 1999-10-18 | 2002-04-02 | Recordati, S.A., Chemical And Pharmacueticals Company | Isoxazolecarboxamide derivatives |
| SE9904723D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
| USRE46117E1 (en) | 1999-12-22 | 2016-08-23 | Teva Pharmaceuticals International Gmbh | Modulators of dopamine neurotransmission |
| SE9904724D0 (sv) | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission I |
| GB2362826A (en) * | 2000-06-02 | 2001-12-05 | Lilly Co Eli | A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist |
| JO2654B1 (en) | 2000-09-04 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Multiple aryl caroxa amides are useful as lipid - lowering agents |
| JP4119114B2 (ja) | 2001-11-28 | 2008-07-16 | 広栄化学工業株式会社 | 新規なジヒドロキシ（３−ピリジル）ボラン類 |
| WO2004056774A2 (en) * | 2002-12-19 | 2004-07-08 | Neurogen Corporation | Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| US7288538B2 (en) | 2003-02-20 | 2007-10-30 | Encysive Pharmaceuticals, Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| US7319111B2 (en) | 2003-02-20 | 2008-01-15 | Encysive Pharmaceuticals, Inc. | Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| PL1664016T3 (pl) | 2003-09-22 | 2009-04-30 | Euro Celtique Sa | Środki terapeutyczne przydatne do leczenia bólu |
| EP1664041B1 (en) | 2003-09-22 | 2008-07-02 | Euro-Celtique S.A. | Phenyl-carboxamide compounds useful for treating pain |
| US7037927B2 (en) * | 2003-10-16 | 2006-05-02 | Abbott Laboratories | Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| ATE473967T1 (de) * | 2003-11-26 | 2010-07-15 | Pfizer Prod Inc | Aminopyrazolderivate als gsk-3-inhibitoren |
| WO2005073193A1 (en) * | 2004-01-23 | 2005-08-11 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| JP2007526332A (ja) * | 2004-03-02 | 2007-09-13 | ニューロジェン・コーポレーション | ヘテロアルキル置換ビフェニル−４−カルボン酸アリールアミド類縁体 |
| SE0401465D0 (sv) | 2004-06-08 | 2004-06-08 | Carlsson A Research Ab | New substituted piperdines as modulators of dopamine neurotransmission |
| US7851629B2 (en) | 2004-06-08 | 2010-12-14 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| DE602005021641D1 (de) | 2004-06-08 | 2010-07-15 | Nsab, Filial Af Neurosearch Sweden Ab | Neue disubstituierte phenylpiperidine und piperazine als modulatoren der dopamin-neurotransmission |
| CA2584831C (en) | 2004-10-13 | 2013-09-17 | Neurosearch Sweden Ab | Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine |
| SE529246C2 (sv) | 2005-10-13 | 2007-06-12 | Neurosearch Sweden Ab | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission |
| PT2125822E (pt) * | 2006-12-21 | 2015-01-30 | Nerviano Medical Sciences Srl | Derivados de pirazol-quinazolina substituídos, processo para sua preparação e seu uso como inibidores da quinase |
| KR100851044B1 (ko) * | 2007-08-21 | 2008-08-12 | (주)아모레퍼시픽 | 미백효과를 나타내는 3,5-디히드록시 벤즈아미드 유도체,및 이를 함유하는 화장료 조성물 |
| EP2297097A2 (en) * | 2008-06-11 | 2011-03-23 | Irm Llc | Compounds and compositions useful for the treatment of malaria |
| CA2778720C (en) * | 2009-11-13 | 2020-06-16 | Packers Plus Energy Services Inc. | Stage tool for wellbore cementing |
| US8846671B2 (en) * | 2010-07-01 | 2014-09-30 | Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences | Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| MX347209B (es) | 2011-12-08 | 2017-04-19 | Teva Pharmaceuticals Int Gmbh | La sal de bromhidrato de pridopidina. |
| HK1206297A1 (en) | 2012-04-04 | 2016-01-08 | Teva Pharmaceuticals International Gmbh | Pharmaceutical compositions for combination therapy |
| WO2016028971A1 (en) * | 2014-08-21 | 2016-02-25 | Bristol-Myers Squibb Company | Tied-back benzamide derivatives as potent rock inhibitors |
| CN108219913B (zh) * | 2018-02-27 | 2021-07-20 | 浙江绿保再生资源科技有限公司 | 一种复合絮凝剂及废润滑油絮凝再生工艺 |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3192213A (en) * | 1962-10-12 | 1965-06-29 | Olin Mathieson | Aminoalkyl anilides |
| DE1668723A1 (de) * | 1966-09-16 | 1971-04-08 | Toyo Jozo Kk | Verfahren zum Herstellen von Verbindungen mit Saeureamid-Bindung |
| AU499714B2 (en) * | 1974-10-14 | 1979-05-03 | Chugai Seiyaku Kabushiki Kaisha | Bis(benzamido)-benzene derivatives & process for preparing thesame |
| US4058523A (en) * | 1974-10-14 | 1977-11-15 | Chugai Seiyaku Kabushiki Kaisha | Bis(benzamido)-benzene derivatives |
| US4735959A (en) * | 1981-01-10 | 1988-04-05 | Dr. Karl Thomae Gmbh | Carboxylic acid amides and pharmaceutical compositions containing them |
| DE3100575A1 (de) * | 1981-01-10 | 1982-09-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue benzoesaeuren, ihre herstellung und ihre verwendung als arzneimittel" |
| US4562201A (en) * | 1982-07-26 | 1985-12-31 | American Hospital Supply Corporation | Aminomethyl benzanilides |
| US4778796A (en) * | 1985-07-19 | 1988-10-18 | Dainippon Pharmaceutical Co., Ltd. | ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same |
| JPH0813759B2 (ja) * | 1986-09-01 | 1996-02-14 | 富士写真フイルム株式会社 | アルコキシベンゼン誘導体の製造方法 |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| EP0324521A3 (en) * | 1988-01-11 | 1991-11-27 | Duphar International Research B.V | Method of treating haematologic diseases and pharmaceutical compositions to be used therefor |
| EP0365064B1 (en) * | 1988-10-10 | 1992-10-21 | Akzo N.V. | Substituted aromatic compounds having an action on the central nervous system |
-
1991
- 1991-09-18 GB GB919119932A patent/GB9119932D0/en active Pending
-
1992
- 1992-09-14 CZ CS94611A patent/CZ61194A3/cs unknown
- 1992-09-14 EP EP92202805A patent/EP0533267A1/en not_active Withdrawn
- 1992-09-14 WO PCT/EP1992/002136 patent/WO1993006084A1/en not_active Ceased
- 1992-09-14 AU AU25687/92A patent/AU2568792A/en not_active Abandoned
- 1992-09-17 US US07/946,099 patent/US5358948A/en not_active Expired - Fee Related
- 1992-09-17 JP JP4273660A patent/JPH06107637A/ja active Pending
- 1992-09-17 CA CA002078507A patent/CA2078507A1/en not_active Abandoned
- 1992-09-17 ZA ZA927106A patent/ZA927106B/xx unknown
- 1992-09-17 IL IL103199A patent/IL103199A0/xx unknown
- 1992-09-17 MX MX9205278A patent/MX9205278A/es unknown
- 1992-09-17 AU AU24528/92A patent/AU2452892A/en not_active Abandoned
- 1992-09-17 CN CN92111661A patent/CN1073430A/zh active Pending
-
1993
- 1993-01-09 CN CN93100710A patent/CN1089944A/zh active Pending
-
1994
- 1994-03-17 FI FI941261A patent/FI941261A7/fi not_active Application Discontinuation
- 1994-03-17 NO NO940974A patent/NO940974D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2568792A (en) | 1993-04-27 |
| MX9205278A (es) | 1993-03-01 |
| FI941261A0 (fi) | 1994-03-17 |
| US5358948A (en) | 1994-10-25 |
| CN1073430A (zh) | 1993-06-23 |
| AU2452892A (en) | 1993-03-25 |
| IL103199A0 (en) | 1993-02-21 |
| GB9119932D0 (en) | 1991-10-30 |
| CA2078507A1 (en) | 1993-03-19 |
| WO1993006084A1 (en) | 1993-04-01 |
| ZA927106B (en) | 1994-03-17 |
| CN1089944A (zh) | 1994-07-27 |
| CZ61194A3 (en) | 1994-11-16 |
| JPH06107637A (ja) | 1994-04-19 |
| EP0533267A1 (en) | 1993-03-24 |
| NO940974D0 (no) | 1994-03-17 |
| FI941261A7 (fi) | 1994-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO940974L (no) | Benzanilid-derivater som 5-HT1D antagonister | |
| DK0533268T3 (da) | Benzanilidderivater som 5HT-1D antagonister | |
| DK0516349T3 (da) | 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister | |
| FI933167A7 (fi) | N-alkyylikinuklidiniumsuolat aineen P antagonisteina | |
| FI924159A7 (fi) | Bentsanilidijohdokset | |
| FI921675L (fi) | En detergentsammansaettning innehaollande polyimidbiopolymer som blir hydrolyserad i tvaettningsvatten | |
| FI924091A7 (fi) | Autoriseringsprotokoll som foersiktighetshjaelpmedel | |
| FI935842A7 (fi) | Anvaendning av tetrahydrokarbazonderivat som 5ht1 -reseptoragonister | |
| DK0514667T3 (da) | Benzazepinderivater som vasopressinantagonister | |
| MX9205145A (es) | Nuevos derivados heterociclicos. | |
| NO953406D0 (no) | Pyrrolo-pyridinderivater | |
| DE69208877D1 (de) | Chinuclidinderivate | |
| FI921556L (fi) | Plasttillslutning som visar otillboerlig anvaendning | |
| FI921182L (fi) | Velangummi som snabbt hydratiseras | |
| FI961628A7 (fi) | Indolijohdannaisia NMDA-antagonisteina | |
| NO920675D0 (no) | Sementadditiv, fremgangsmaate for fremstilling av additivet, samt sement som inneholder additivet | |
| FI935944L (fi) | Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer | |
| FI925330L (fi) | Substituerade fenylfenoler som leukotrienantagonister | |
| FI924571L (fi) | Foerfarande foer binaer kodning av punkter i en punktgrupp som anvaends i multibaervaogsmodulering av ofdm-typ | |
| FI921133L (fi) | Faktor, som stimulerar neu-receptorn | |
| FI951798A0 (fi) | Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina | |
| FI920394A7 (fi) | 3-kinuklidiinijohdannaiset | |
| FI943513A0 (fi) | Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja | |
| FI934017A7 (fi) | Vaermeanordning som anvaender fast braensle | |
| FI923555L (fi) | Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt |